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ABSTRACT Aspergillus nidulans contains two functionally
distinct fatty acid synthases (FASs): one required for primary
fatty acid metabolism (FAS) and the other required for
secondary metabolism (sFAS). FAS mutants require long-
chain fatty acids for growth, whereas sFAS mutants grow
normally but cannot synthesize sterigmatocystin (ST), a car-
cinogenic secondary metabolite structurally and biosyntheti-
cally related to af latoxin. sFAS mutants regain the ability to
synthesize ST when provided with hexanoic acid, supporting
the model that the ST polyketide synthase uses this short-
chain fatty acid as a starter unit. The characterization of both
the polyketide synthase and FAS may provide novel means for
modifying secondary metabolites.
Fatty acids (FAs) and polyketides (PKs) are structurally
dissimilar molecules that are synthesized by the evolutionarily
related fatty acid synthase (FAS) and polyketide synthase
(PKS), respectively (1). Both types of enzymes facilitate the
reiterative condensation of simple carboxylic acids; typically,
acetyl-CoA serves as a starter unit and malonyl-CoA serves as
an extender unit. In the case of FASs, the b-keto group
generated by the condensation is always fully reduced by a
cycle of reactions (keto reduction, dehydration, and enoyl
reduction) before the next condensation reaction. Some or all
of this reduction cycle can be omitted by the PKS and accounts
for much of the structural diversity found in this class of natural
compounds.
The long-chain FAs produced by known FASs have a
primary function in the cell where the vast majority are found
incorporated as lipids into membranes or storage bodies. In
contrast, many PKs produced by PKSs have obscure or un-
known functions in the producing organism and are typically
classified as secondary metabolites. However, many PKs have
tremendous importance to man in that they display a broad
range of useful antibiotic and immunosuppressant activities as
well as less desirable phyto- and mycotoxic activities.
Perhaps the most infamous PK is the mycotoxin aflatoxin
(AF), which is among the most highly toxic, carcinogenic
natural products known (2). AF was first characterized in 1960
following the death of more than a hundred thousand poultry
in England that had ingested AF-contaminated peanut meal
(3). This discovery quickly led to legislation regulating trade of
AF-contaminated agricultural commodities at both the na-
tional and international levels. Compliance to these regula-
tions causes the loss of millions of dollars in produce in the
United States each year; trade sanctions and health effects
likely triple these losses. In Third-World nations that do not
have the ways, means, or luxury to destroy contaminated foods,
a high incidence of human liver cancers is correlated in certain
geographic areas with the ingestion of AFs (4). In fact, it has
been shown that AF-induced liver cancer is linked to a specific
mutation in the tumor suppressor gene p53 (5–7).
While only a few fungal species synthesize AF, at least 20
species (including Aspergillus nidulans) produce the biosyn-
thetically-related compound sterigmatocystin (ST; Fig. 1). The
PK precursor of ST and AF is norsolorinic acid, and was
originally assumed to be produced by a PKS catalyzing 10
condensations and two reduction cycles (2, 8). However, the
presence of an aliphatic moiety adjacent to a keto group in
norsolorinic acid could also be explained by a novel PK
assembly mechanism in which the STyAF PKS used a short-
chain FA (hexanoyl-CoA) as the starter unit instead of acetyl-
CoA (Fig. 1) (9). This second hypothesis is supported by two
lines of evidence. First, feeding studies demonstrated that C6
chains (via hexanoic acid) can be incorporated intact into
STyAF pathway intermediates (9, 10). Second, recent genetic
studies showed that genes encoding a FAS homolog are linked
to genes previously shown to be required for STyAF biosyn-
thesis (11, 12). The work presented here demonstrates that the
FAS homolog linked to the A. nidulans ST gene cluster is
indeed necessary for ST biosynthesis. In addition, we describe
a second pair of linked genes in A. nidulans encoding a
different FAS homolog and show that they are required for
synthesis of long-chain FAs for primarymetabolism but are not
needed for ST production.
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FIG. 1. SterigmatocystinyAF pathway. The aliphatic moiety of
norsolorinic acid, the first intermediate in the pathway, is enclosed in
a box.
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MATERIALS AND METHODS
Fungal Strains and Growth Conditions. All A. nidulans
strains used in this study are described in Table 1. Conidial
suspensions (1 3 106 spores per ml) were generated after
growth on minimal media (MM) with appropriate supple-
ments (13). FA-requiring strains were grown on MM plus 2
mM myristic acid (n-tetradecanoic acid, Sigma), 0.1% Tween
40 (Sigma), and biotin or MM plus 3.0% oatmeal (Quaker
Oats, Chicago) (MMO) and biotin.
Nucleic Acid Manipulations. Standard molecular tech-
niques were used to manipulate DNA in vitro (14). DNA
probes were generated by labeling fragments with 32P by
random primer extension as described by Sambrook et al. (14).
ST Production and Detection. A. nidulans ST production
was induced by inoculating 40 ml MMO shake cultures (300
rpm at 308C) containing appropriate supplements for auxo-
trophic requirements (Table 1). No FA supplementation was
required for fasA2 and fasB2 mutant strains grown on this
medium. For feeding studies, n-hexanoic acid, n-octanoic acid,
or n-decanoic acid (20 mg, Sigma) was added to the medium at
24, 48, 72, andyor 96 hr after inoculation. After 120 hr, the
cultures were extracted with equal volume acetone followed by
equal volume chloroform as described (15). Extracts from the
strains indicated were spotted on a precoated TLC plate
(Analtech) along with 100 ng of ST standard (Sigma). Samples
were resolved using tolueneyethyl acetateyglacial acetic acid
(80:10:10 volyvolyvol). The plates were then dried, sprayed
with 20% aluminum chloride in 95% ethanol, and baked at
958C for 10 min. Although ST could be readily observed as a
bright yellow color under fluorescent light, additional UV-
absorbing material comigrated with ST. Therefore, the region
from each lane having the equivalent retention factor to ST
was recovered from the plate, eluted with chloroform, and
spotted onto a second TLC plate to reduce the number of
comigrating compounds. These samples were resolved with
benzeneyglacial acetic acid (95:5 volyvol).
Sequence Analysis. Approximately 25 restriction endonu-
clease fragments of the chromosome VIII specific cosmid
pW19E9 were inserted into the vectors pBluescript KS
(Stratagene) and pK19 (16, 17). DNA sequencing of both
strands was performed using synthetic primers and the
SequiTherm Cycle Sequencing Kit (Epicentre Technology,
Madison, WI) according to the manufacturer’s directions as
well as the ABI PRISM DNA Sequencing Kits (Perkin–
Elmer). Nucleotide sequence was translated in all six reading
frames and compared with the protein data bases (Swiss-
PROT and GenBankyEuropean Molecular Biology Labora-
tory) by the BLASTX 1.4 program (18, 19). Amino acid
sequences were analyzed by the GAP, PILEUP, and PRETTY
programs of the Genetics Computer Group (Madison, WI)
sequence analysis software package (20). The GenBank
accession no. for fasA and fasB is U75347 and for stcJ and
stcK is U34740 (coordinates 25134 to 36275).
Gene Disruption Vectors and Transformation. Each gene
was disrupted by replacing an internal portion of the coding
region with a selectable marker using standard transformation
procedures (21). The disruption vector pNK17 (targeting stcJ)
was created by exchanging a 1.3-kb BamHI fragment in pNK16
with a BamHI fragment containing argB gene from pSalArgB.
This results in a truncated StcJ at amino acid 430, effectively
removing the ketoreductase and ketosynthase domains.
pNK16 is an EcoRIyXbaI subclone of cosmid pL11C09. The
disruption vector pDB14 (targeting stcK) was created by
exchanging a 2.4-kb XhoI fragment in pDB13 with XhoI
fragment containing trpC gene from pTL11. This results in a
truncated StcK at amino acid 713, effectively removing the
enoyl reductase, dehydrase, andmalonylypalmitoyl transferase
domains. pDB13 is a KpnI subclone of cosmid pL11C09.
The disruption vector pDB51 (targeting fasA) was created
by using argB to ligate together two plasmids (pDB36 and
pDB26) containing distal ends of the coding sequence of fasA
such that a 2.2-kb fragment of fasA was replaced with argB.
This results in a truncated FasA at amino acid 100, effectively
removing all three active site domains (acyl carrier protein,
ketoreductase, and ketosynthase domains). The disruption
vector pDB57 (targeting fasB) was created in a similar manner
replacing a 1.3 kb fragment of fasB with argB. This results in
a truncated FasB at amino acid 1390, effectively removing the
dehydrase and malonylypalmitoyl transferase domains.
Identification of Essential FAS Genes. Highly conserved
regions of the a or b subunits of fungal FAS peptides were
identified by sequence alignments (to date, all fungal FASs are
comprised of a and b subunits). The a and b subunits aligned
were from Candida albicans (22, 23), Saccharomyces cerevisiae
(24, 25), Penicillium patulum (28), and Yarrowia lipolytica (26).
Inosine was substituted at highly degenerate positions within
each oligo in some instances to facilitate annealing. The FAS
a primers were 59-GARGGITGYGTIGARATGGCITGGA-
THATGGG-39 and 59-CATCCAIGCNCCIGCNGCICCRT-
TIGGYTGICC-39. The predicted PCR product, based on the
S. cerevisiae FAS2 gene (a subunit), is 980 bp and encompasses
the b-keto acyl synthase domain. The FAS b primers were
59-CKIRGIACIGCIACYTGCATIGTCATICC-39 and 59-GG-
IWSICARGARCARGGIATGGGIATGG-39. The predicted
PCR product, based on the S. cerevisiae FAS1 (b subunit), is 530
bp and encompasses the malonylypalmitoyl transferase domain.
The PCR conditions for amplification were: 35 cycles of 1 min at
948C, 30 s at 508C, and 1 min at 728C. PCR products were
radiolabeled and used to screen a pWE15 cosmid library to
identify putative FAS-containing cosmids (17).
RESULTS
stcJ and stcK Are Required for ST Synthesis but Not Growth.
To test the hypothesis that the FAS genes (stcJ and stcK)
located within the A. nidulans ST gene cluster (12) functioned
specifically in ST biosynthesis, we constructed A. nidulans
strains in which each gene had been disrupted. As shown in Fig.
2, stcJ- and stcK-disrupted strains grew without exogenous
long-chain FAs, indicating that neither gene is required for
normal FAmetabolism. In addition, the stcJ2 and stcK2 strains
were morphologically identical to isogenic wild-type strains
but failed to produce ST under conditions that supported ST
production by wild-type (Fig. 3).
Addition of Hexanoic Acid Restores ST Biosynthesis. To
further test the hypothesis that stcJ and stcK were required for
synthesis of a FA needed for norsolorinic acid synthesis, we
added C6 straight-chain FA (hexanoic acid) to stcJ2 and stcK2
mutant strains grown under ST-producing conditions. As
shown in Fig. 3, ST synthesis was restored upon the addition
of hexanoic acid to the culture media. In contrast, hexanoic
acid failed to restore ST biosynthesis in a stcA2 (PKS dis-
rupted) strain (27). This confirmed the need of both FAS and
PKS enzymes for ST synthesis.
Table 1. A. nidulans strains used in this study
Strains Genotype Source
FGSC237 pabaA1, yA2, trpC801, veA1 FGSC*
FGSC89 argB2, biA1, veA1 FGSC
PW1 biA1, argB2, methG1, veA1 Ref. 35
TTAARG biA1, methG1, veA1 Ref. 35
TTA11 pabaA1, yA2, veA1 Ref. 36
TDB1 stcJ, biA1, methG1, veA1 This study
TDB5 stcK, pabaA1, yA2, veA1 This study
TDB51.1 fasA, biA1, veA1 This study
TDB57.1 fasB, biA1, veA1 This study
JYP1-13 biA1, veA1, stcA Ref. 27
*Fungal Genetics Stock Center (Kansas City, MO).
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An alternative source of the C6 carbon-chain (versus de novo
synthesis) could be b-oxidation of long-chain FAs. This ap-
pears not to be the case as the addition of neither C8
(n-octanoic acid) nor C10 (n-decanoic acid) restored ST syn-
thesis in stcJ2 and stcK2 strains (data not shown). In addition,
we did not observe the appearance of any new metabolites
suggesting that the PKS cannot use these FAs, or does so at an
efficiency too small to detect the products by TLC.
fasA and fasB Are Required for Growth but Not ST Syn-
thesis. Our finding that StcJ and StcK [encoding a FAS
involved in secondary metabolism (sFAS)] were only required
for production of a PK and not required for primary FA
biosynthesis led us to investigate the possibility that a different
FAS was responsible for long-chain FA synthesis in A. nidu-
lans. The two sets of degenerate FAS primers (specific for the
gene encoding either the FAS a or b subunit) generated
predicted size fragments from A. nidulans genomic DNA.
Direct sequencing of these fragments indicated that they were
distinct from analogous stcJ and stcK fragments. The chromo-
someVIII specific cosmid pW19E9 hybridized to both the FAS
a and b specific probes and in fact was found to contain full
copies of each gene, which were named fasA and fasB, respec-
tively. Fig. 2 shows that disruption of either fasA or fasB
resulted in strains that were unable to grow on minimal
medium unless supplemented with myristic acid (C14 straight
chain FA). FAs of less than C12 were unable to complement
these mutations (data not shown). In contrast to stcJ2 and
stcK2 strains, fasA2 and fasB2 strains were able to produce ST
(Fig. 3).
Comparison of the Essential FAS with the sFAS. The FAS2
(a subunit) and FAS1 (b subunit) peptide sequences from
Penicillium, Candida, Saccharomyces, Yarrowia, and A. nidu-
lans FasA and FasB share between 60% to 70% identity,
respectively (Fig. 4). In contrast, the highest identity shared by
StcJ (sFAS a) is 44% with Penicillium and the highest identity
shared by StcK (sFAS b) is 37% with Yarrowia (12). Never-
theless, the eight active site domains (three on the a subunit
and five on the b subunit) required for constitutive FA
synthesis in S. cerevisiae were present in both A. nidulans FAS
sets and were arranged in the same colinear manner as
reported for all fungal FASs. In addition, both sets of genes are
divergently transcribed from a shared promoter region; ap-
proximately 550 nucleotides separate the putative stcJ and stcK
start codons and approximately 1700 nucleotides separate the
putative fasA and fasB start codons.
DISCUSSION
The finding that the STyAF PKs are synthesized through the
activity of both a PKS and a FAS defines a novel route for the
synthesis of a secondary metabolite. There are several exam-
ples in the literature of secondary metabolites derived from
products of de novo FA biosynthesis, but the FA source has not
been determined and has been assumed to involve FAs from
primary metabolism (ref. 29 and references therein). In most
cases, these secondary metabolites are not PKs, but it has been
suggested that the PKS involved in benastanin (a Streptomyces
metabolite) synthesis may use hexanoic acid as a starter unit
(29). This hypothesis has not been tested and no information
about the possible source of the putative FA starter is avail-
able. The finding that a distinct FAS is dedicated to STyAF
metabolite production is novel but is probably not specific to
this pathway. For example, it has recently been shown that a
FAS with significant identities to fungal FAS1 (encoding the
b subunit) is required for production of HC toxin, a tetrapep-
tide produced by the fungus Cochliobolus carbonum (ref. 30
and J. D. Walton, personal communication). To date, the
precise role of the FAS b in HC toxin synthesis has not been
demonstrated, but it does not affect growth and is proposed to
function in the synthesis of the decanoic acid moiety attached
to an amino acid in the tetrapeptide (J. D. Walton, personal
communication).
FIG. 2. Growth requirements of the strains disrupted in the two FASs. From the top clockwise: TTAARG (wild type), TDB57.1 (fasB2), TDB5
(stcK2), TDB1 (stcJ2), and TDB51.1 (fasA2). Minimal media (B) and minimal media plus 2 mM myristic acid (n-tetradecanoic acid, Sigma) (A).
FIG. 3. ST analysis of oatmeal culture extracts by TLC. Approxi-
mately 20 times as much material from stcJ2 and stcK2 mutants was
loaded as compared with wild type and samples were resolved with
benzeneyglacial acetic acid (95:5 volyvol). The nature of the band
above ST is unknown.
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It is interesting that Aspergillus has a unique FAS that is
apparently dedicated to the synthesis of a short-chain FA used
in secondary metabolism as well as an essential FAS that
synthesizes long-chain FAs required for primary growth. The
synthesis of short-chain FAs has been best characterized in
plants where it occurs throughmodified branched-chain amino
acid metabolism (31). These short-chain FAs have never been
shown to be involved in PK synthesis, but are commonly found
as components of esters that have poorly characterized func-
tions (31). The synthesis of the hexanoate moiety that likely
primes ST PKS clearly occurs by a different mechanism that is
more akin to long-chain FA synthesis. Nevertheless, it remains
possible that the sFAS is able to synthesize long-chain FAs but
fails to complement fasA and fasB mutations because it is only
active late in the life cycle. In any case, the sFASmust also have
an unprecedented ability to synthesize short-chain FAs.
Considerable efforts have been expended to understand
how organisms control or regulate FA chain length. In general,
constitutive FA synthesis results in the production of long-
chain FAs (.C12). In plants and bacteria, the proportion of
different length FAs generated by the type II FAS complex is
controlled by the activities of the ketosynthase and acyl-acyl
carrier protein thioesterase domains (32). The mechanism
regulating FA chain length for the mammalian type I FAS is
not clear but it can involve tissue specific control by a distinct
thioesterase activity (33). As yet, the mechanism controlling
FA chain length in fungi has not been addressed but no known
fungal FAS has an obvious thioesterase domain. Thus regu-
lation of FA chain length in fungi is likely controlled by some
aspect of the ketosynthase domain or by an uncharacterized
activity. Understanding the mechanism allowing sFAS to
synthesize short-chain FAs while the essential FAS synthesize
long-chain FAs is likely to help define the complex program
controlling FA chain length by differing FASs.
Finally, the demonstration of an FA-primed PKS has im-
portant implications to molecular engineering of PKs. The
ability of the PKS to synthesize ST from exogenous hexanoic
acid in sFAS mutants implies that it is able to load this unique
length starter without a functional sFAS and then initiate the
cycles of condensation reactions leading to norsolorinic acid.
Watanabe et al. (34) suggested that the Aspergillus parasiticus
STyAF PKS must interact directly with the STyAF FAS
homologs of StcJ and StcK for efficient incorporation of
hexanoate into norsolorinic acid. In support of this hypothesis,
stcJ2 and stcK2 mutant strains grown with hexanoic acid
accumulated approximately 20-fold less ST than did wild type
grown under the same conditions. While this decreased accu-
mulation of ST could be due to a need for sFASyPKS
interactions, there are other explanations and the clear reso-
lution of this question will require in vitro experiments mea-
suring the activity of all three enzymes. In any case, under-
standing the mechanism by which the STyAF PKS and FAS
cooperate in synthesizing STyAF may provide additional tools
for engineering PK diversity.
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